Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin plus tenofovir for chronic hepatitis B
IRCT20110621006852N2Phase 2Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Chronic Hepatitis B (CHB) comparing Atorvastatin + tenofovir with Placebo + tenofovir control (2 arms). Primary endpoints: HBV viral load and Liver enzymes. Started Apr 2013; status: completed.
02
Drugs
atorvastatintenofovir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on IRCT20110621006852N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110621006852N2.